PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2007
CASE
AUTH/1966/2/07 ALK-AbellΓ³

ALK-AbellΓ³: β€˜Curing Allergy’ strapline in EpiPen Dear Doctor letter ruled an inaccurate, unsubstantiated product claim (AUTH/1966/2/07)

A GP challenged β€˜Curing Allergy’ on an EpiPen Dear Doctor letter. PMCPA said even as part of a logo it was a…

2007
CASE
AUTH/1938/1/07 Sanofi

AUTH/1938/1/07: GlaxoSmithKline v Sanofi Pasteur MSD β€” Gardasil journal ad claims (no breach)

Intercompany complaint about Gardasil journal ad claims on cervical cancer prevention and β€œBenefit from 4 types”. Panel concerns on ambiguity were superseded…

2006
CASE
AUTH/1932/12/06 Novo Nordisk

AUTH/1932/12/06: Anonymous v Novo Nordisk β€” diabetes helpline staffed by NHS clinic nurses (No breach)

Complaint alleged Novo Nordisk’s out-of-hours diabetes helpline (for users of its products) improperly incentivised nurses who also worked in NHS clinics. PMCPA…

Sanofi

Sanofi-Aventis Acomplia (rimonabant) GP ad: cardiometabolic risk messaging ruled misleading

A GP journal ad for Acomplia was ruled misleading: it implied use in all overweight patients and suggested broad cardiometabolic benefits beyond…

2006
CASE
AUTH/1807/3/06 Pfizer ⭐ Case of the Week

Pfizer: sponsored nurse audit programmes and β€œvalue added” services linked to Lipitor targeting (AUTH/1807/3/06 & AUTH/1810/3/06)

Sunday Times alleged nurses were paid/bonused to influence prescribing. Panel found most audits acceptable, but breached the Code where a nurse programme…

2017
CASE
AUTH/2996/12/17 Seqirus

AUTH/2996/12/17: Pharmacist v Seqirus β€” Fluad promotional email and β€œnew guidance/policy change” wording (No breach)

A pharmacist alleged a Seqirus promotional email about Fluad implied JCVI policy had changed to recommend Fluad for all 65+. Panel found…

2015
CASE
AUTH/2762/5/15 Astellas

Astellas: Clinical trial disclosure (Betmiga) β€” No breach (outwith scope of the Code) (AUTH/2762/5/15)

PMCPA case AUTH/2762/5/15 (Director v Astellas) about clinical trial disclosure for Betmiga. The matter was ruled outwith the scope of the Code…

2018
CASE
AUTH/3016/1/18 Takeda

AUTH/3016/1/18: Consultant Haematologist v Takeda (Alleged religious discrimination) – No breach / Out of scope

PMCPA case AUTH/3016/1/18 (2016 Code): complaint by a consultant haematologist alleging religious discrimination against Takeda. Outcome: no breach; matter found outwith the…

2006
CASE
AUTH/1849/6/06 AstraZeneca

AUTH/1849/6/06: Media/Director v AstraZeneca β€” disclosure of patient group involvement (No breach)

Financial Times alleged AstraZeneca delayed disclosing patient group funding. PMCPA held website vs annual report disclosure are alternatives under Clause 20.3; AstraZeneca’s…

2006
CASE
AUTH/1797/2/06 Bayer ⭐ Case of the Week

AUTH/1797/2/06: Editor of a Pharmacy Journal v Bayer (Levitra) β€” celebrity endorsement complaint (No breach)

Complaint about celebrity comments praising Levitra in BBC and Saga online articles linked to SortEDin10. PMCPA ruled celebrity endorsement isn’t prohibited per…

2007
CASE
AUTH/2028/7/07 Sanofi

AUTH/2028/7/07: Novo Nordisk v Sanofi-Aventis – β€œ24-hour glycaemic control” claims for Lantus

Appeal Board found β€œ24-hour glycaemic control” claims for Lantus exaggerated and misleading: once-daily basal insulin action did not equal 24-hour glycaemic control.…

2007
CASE
AUTH/2007/5/07 Teva

Teva UK misleading superiority claim for Qvar leavepiece: β€œTwice as many symptom-free days” (AUTH/2007/5/07)

A Qvar leavepiece claimed β€œTwice as many symptom-free days” vs CFC-BDP. PMCPA found the pharmacoeconomic analysis cited wasn’t robust enough for such…

2019
CASE
AUTH/3175/3/19 GlaxoSmithKline

GSK misleadingly implied NICE endorsement for Anoro Ellipta and blurred licensed indication context (AUTH/3175/3/19)

A COPD ad featuring a prominent β€œNICE 2018” badge and Anoro imagery was ruled misleading, implying NICE recommended Anoro and implying an…

2006
CASE
AUTH/1865/7/06 Bristol-Myers Squibb Pharmaceuticals

Anonymous v Bristol-Myers Squibb (AUTH/1865/7/06): Football club venue for PCT education meeting found acceptable

Anonymous complaint alleged a Code breach for sponsoring a meeting at a football club. Panel found the venue acceptable given delegate numbers,…

Abbott ⭐ Case of the Week

Abbott: media report of gay bar visit with consultant led to hospitality complaint (Appeal Board: no breach)

The Sun alleged Abbott reps attended a Glasgow gay bar with a hospital consultant. Panel found hospitality/Clause 2 breaches, but on appeal…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training